MyFinsight
Home
Blog
About
Contact
Download
Download image
Unrealized gains on
available-for-sale securities
$69,141
Comprehensive loss
-$10,041,211
Total other
comprehensive income
$45,476
Foreign currency
translation
-$23,665
Net loss
-$10,086,687
Interest income
$717,168
Loss before
provision for income taxes
-$10,086,687
Total other income
(expense), net
$717,168
Loss from operations
-$10,803,855
Total operating
expenses
$10,803,855
Research and development
$5,980,477
General and
administrative expenses
$4,823,378
Back
Back
Income Statement
source: myfinsight.com
Immix Biopharma, Inc. (IMMX)
Immix Biopharma, Inc. (IMMX)